Lead Nurse Bowel Cancer Screening Programme

Main area Gastroenterology Grade NHS AfC:
Band 7 Contract Permanent:
Mon - Friday excluding BH Hours Full time - 37.5 hours per week (Mon - Fri, Excluding BH) Job
-ME05383

Employer University Hospitals Dorset NHS Foundation Trust Employer type NHS Site Poole Town Poole Salary £47,810 - £54,710 Per annum Salary period Yearly Closing 18/01/2026 23:59

As University Hospitals Dorset we are a three site acute trust with ‘university hospital’ status through our partnership with Bournemouth University, working with an annual budget of £730m.

We offer highly regarded health services, employing some 10,000 staff. Our ambitious £500m transformation programme is well on the way to delivering state‑of‑the‑art facilities over the next two years to meet the current and future healthcare needs of the populations we serve.

In an Area of Outstanding Natural Beauty with over seven miles of sandy beaches you’ll find inspirational opportunities to achieve your perfect work/life balance. With the New Forest and the Purbecks on our doorstep, we’re also less than three hours from London by road or train. The thriving towns of Poole, Bournemouth and Christchurch give way to idyllic villages and unspoilt landscapes just minutes from our hospitals.

We believe that having a diverse workforce, and allowing people to be themselves, is essential in ensuring we offer an inclusive, welcoming and productive place to work.

We especially welcome applications from minority groups in the community who may be underrepresented in our workforce.

At UHD our active staff network groups are the Women's Network, Black Asian Minority Ethnic Group (BAME), Pride Network, European (EU), Pro Ability Staff Network, and the Armed Forces Support Group.

As a Trust we are proudly signed up to the Disability Confident and Armed Forces Covenant guaranteed interview schemes.

We are aware that some candidates may choose to use AI tools to support the preparation of their application. While this is not discouraged, we kindly remind applicants that submissions should remain an honest and accurate representation of your own experience and suitability. Personal integrity is an important part of the recruitment process.

Lead Nurse for Bowel cancer screening programme

Interview date: 26th January 2026

UHD are investing, developing and transforming Trust services in line with the New Hospital Programme. As part of this, some services may move site this year or next, either temporarily or permanently. Recruiting Managers will be happy to answer any service‑specific questions at interview.

If a role or service relocates as part of a planned move, excess mileage will not be reimbursed. Travel from home to the new work base will be classed as a normal commute. Any other changes will be managed under Trust or national terms and conditions.

UHD has active networks including Women’s, BAME, Pride, EU, Pro Ability, and Armed Forces. We support Disability Confident and Armed Forces Covenant interview schemes.

AI tools may be used, but applications must honestly reflect your own skills and experience. Integrity is key to our recruitment process.

• Degree in relevant subject
• Registration on Part 1 NMC Register (RGN or RN Adult)
• Knowledge of health promotion
• Specialist Screening Practitioner module at either level 6 or 7
• Specialist knowledge of national and local agenda on improving cancer services, specifically colorectal cancer, endoscopic procedures, valid consent and withdrawal of consent

• Significant relevant post‑registration education and experience, Relevant clinical experience within an acute field.
• Experience of leading a team
• Experience of providing training and education, Experience of quality assurance, audit and research. Experience of autonomous practice
• Experience as a Specialist Screening Practitioner within the BCSP.
• Relevant clinical experience within colorectal/gastroenterology/endoscopy
• Proficient computer skills and use of MS Office (Word, Excel, PowerPoint), and experience with use of hospital databases (e.g. EPR, etc.)
• Evidence…